Affordability and sustainability. Difference between HTA and payer perspective. What is Europe's challenge? How to influence reimbursement decisions as a patient advocate?

Economic decisions in the healthcare area are often between affordability and sustainability. How can patient advocacy groups influence reimbursement decisions is an important question.

Presentation at the WECAN Academy 2019:

Presenter: Zack Pemberton-Whiteley, Acute Leukaemia Network

The following presentation held at the WECAN Academy 2019 will help you to understand:

• The basics of affordability and sustainability of healthcare systems
• The difference between HTA and payer perspective
• The specific challenges across Europe, especially the east-west divide on GDP, pricing and access
• Sustainability and reimbursement are decisions on the national, not EU level – but that this explains opposition of MS to give EU any say in pricing and reimbursement, as it’s not the EU budget which is affected
• How to influence reimbursement decisions as a patient advocate
• How to position as patient advocate between a rock and a hard place, between affordability and sustainability